Naltrexone in the Treatment of Alcohol Dependence
Open accessAbstract
BACKGROUND: Although naltrexone, an opiate-receptor antagonist, has been approved by the Food and Drug Administration for the treatment of alcohol dependence, its efficacy is uncertain. METHODS: We conducted a multicenter, double-blind, placebo-controlled evaluation of naltrexone as an adjunct to standardized psychosocial treatment. We randomly assigned 627 veterans (almost all men) with chronic, severe alcohol dependence to 12 months of naltrexone (50 mg once daily), 3 months of naltrexone followed by 9 months of placebo, or 12 months of placebo. All patients were offered individual counseling and programs to improve their compliance with study medication and were encouraged to attend Alcoholics Anonymous meetings. RESULTS: There were 209 patients in each group; all had been sober for at least five days before randomization. At 13 weeks, we found no significant difference in the number of days to relapse between patients in the two naltrexone groups (mean, 72.3 days) and the placebo group (mean, 62.4 days; 95 percent confidence interval for the difference between groups, -3.0 to 22.8). At 52 weeks, there were no significant differences among the three groups in the percentage of days on which drinking occurred and the number of drinks per drinking day. CONCLUSIONS: Our findings do not support the use of naltrexone for the treatment of men with chronic, severe alcohol dependence.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,232 · see citing works
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158 · see citing works
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875 · see citing works
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828 · see citing works
Naltrexone and Coping Skills Therapy for Alcohol Dependence
O’Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,466 · see citing works
Alcohol dependence syndrome: Measurement and validation.
Skinner, H. A., & Allen, B. A. (1982) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.91.3.199 · Cited by 1,061 · see citing works
Sobell, L. C., Sobell, M. B., Leo, G. I., & Cancilla, A. (1988) · British Journal of Addiction · doi:10.1111/j.1360-0443.1988.tb00485.x · Cited by 777 · see citing works
Alcohol dependence syndrome: Measurement and validation.
Skinner, H. A., & Allen, B. A. (1982) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.91.3.199 · Cited by 772 · see citing works
Endogenous opioid systems and alcohol addiction
Herz, A. (1997) · Psychopharmacology · doi:10.1007/s002130050169 · Cited by 749 · see citing works
Anton, R. F., Moak, D. H., & Latham, P. K. (1995) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01475.x · Cited by 679 · see citing works
Stages of change profiles in outpatient alcoholism treatment
DiClemente, C. C., & Hughes, S. O. (1990) · Journal of Substance Abuse · doi:10.1016/s0899-3289(05)80057-4 · Cited by 654 · see citing works
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.256.11.1449 · Cited by 541 · see citing works
(1993) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1993.tb05219.x · Cited by 503 · see citing works
Pharmacological Treatment of Alcohol Dependence: A Review of the Evidence
Garbutt, J. C., West, S. L., Carey, T. S., Lohr, K. N., & Crews, F. T. (1999) · JAMA · doi:10.1001/jama.281.14.1318 · Cited by 444 · see citing works
Anton, R. F., Moak, D. H., Waid, L. R., Latham, P. K., Malcolm, R. J., & Dias, J. K. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1758 · Cited by 424 · see citing works
Naltrexone and Alcohol Dependence
Volpicelli, J. R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200071010 · Cited by 411 · see citing works
The pharmacological treatment of alcohol dependence.
Swift, R. M. (1997) · PubMed · Cited by 372 · see citing works
Chick, J. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.6.587 · Cited by 310 · see citing works
Effect of naltrexone on alcohol “high” in alcoholics
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.4.613 · Cited by 308 · see citing works
Naltrexone-induced alterations in human ethanol intoxication
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1463 · Cited by 254 · see citing works
Naltrexone vs. Nefazodone for Treatment of Alcohol Dependence A Placebo-Controlled Trial
Kranzler, H. R. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00135-9 · Cited by 209 · see citing works
Naltrexone's Effect on Cue‐Elicited Craving Among Alcoholics in Treatment
Monti, P. M., Rohsenow, D. J., Hutchison, K. E., Swift, R. M., Mueller, T. I., Colby, S. M., Brown, R. A., Gulliver, S. B., Gordon, A. A., & Abrams, D. B. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04361.x · Cited by 188 · see citing works
IMPLICATIONS OF ENDOGENOUS OPIOIDS AND DOPAMINE IN ALCOHOLISM: HUMAN AND BASIC SCIENCE STUDIES
Gianoulakis, C. (1996) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008216 · Cited by 162 · see citing works
Enhancing Patient Compliance in the Elderly
Cramer, J. A. (1998) · Drugs & Aging · doi:10.2165/00002512-199812010-00002 · Cited by 128 · see citing works
Self-citationEnhancing Medication Compliance for People with Serious Mental Illness
Cramer, J. A., & Rosenheck, R. (1999) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199901000-00009 · Cited by 128 · see citing works
Self-citationExperience of a "slip" among alcoholics treated with naltrexone or placebo
O’Malley, S. S., Jaffe, A. J., Rode, S., & Rounsaville, B. J. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.2.281 · Cited by 123 · see citing works
A Double-blind, Placebo-Controlled Trial of Lithium Carbonate Therapy for Alcoholism
FAWCETT, J. A. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800150060008 · Cited by 116 · see citing works
Naltrexone in the Treatment of Alcohol Dependence: A Combined Analysis of Two Trials
O’Malley, S. S., Croop, R. S., Wroblewski, J. M., Labriola, D., & Volpicelli, J. R. (1995) · Psychiatric Annals · doi:10.3928/0048-5713-19951101-11 · Cited by 81 · see citing works
Medications and alcohol craving.
Swift, R. M. (1999) · PubMed Central · Cited by 59 · see citing works
Compliance with disulfiram treatment of alcoholism
Fuller, R. K., Roth, H. P., & Long, S. (1983) · Journal of Chronic Diseases · doi:10.1016/0021-9681(83)90090-5 · Cited by 56 · see citing works
International Update: New Findings on Promising Medications
Litten, R. Z., & Fertig, J. B. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01779.x · Cited by 30 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Collins JF, Dorus W. Patient selection bias in analyses using only com- pliant patients. In: Cramer JA, Spilker B, eds. Patient compliance in med- ical practice and clinical trials. New York: Raven Press, 1991:335-48.
Cited by
Sorted by citations
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930 · see citing works
Gueorguieva, R., & Krystal, J. H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.310 · Cited by 1,529 · see citing works
Self-citationLindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099 · see citing works
Imaginary Relish and Exquisite Torture: The Elaborated Intrusion Theory of Desire.
Kavanagh, D. J., Andrade, J., & May, J. (2005) · Psychological Review · doi:10.1037/0033-295x.112.2.446 · Cited by 956 · see citing works
Jonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., Kim, M. M., Shanahan, E., Gass, C. E., Rowe, C. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.3628 · Cited by 923 · see citing works
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913 · see citing works
Opioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867 · Cited by 762 · see citing works
Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence
Garbutt, J. C., Kranzler, H. R., O’Malley, S. S., Gastfriend, D. R., Pettinati, H. M., Silverman, B. L., Loewy, J. W., Ehrich, E. W., & for the Vivitrex Study Group (2005) · JAMA · doi:10.1001/jama.293.13.1617 · Cited by 632 · see citing works
Saitz, R. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp042262 · Cited by 599 · see citing works
Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571 · see citing works
Alvarez, C. B., Magro, A., Ana, M., & María, A. J. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00763.x · Cited by 504 · see citing works
Camí, J., & Farré, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023160 · Cited by 477 · see citing works
Maisel, N. C., Blodgett, J. C., Wilbourne, P. L., Humphreys, K., & Finney, J. W. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04054.x · Cited by 470 · see citing works
Anton, R. F., Oroszi, G., O’Malley, S., Couper, D., Swift, R., Pettinati, H., & Goldman, D. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.2.135 · Cited by 451 · see citing works
Leeman, R. F., & Potenza, M. N. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2550-7 · Cited by 448 · see citing works
Comparing and Combining Naltrexone and Acamprosate in Relapse Prevention of Alcoholism
Kiefer, F., Jahn, H., Tarnaske, T., Helwig, H., Briken, P., Holzbach, R., Kämpf, P., Stracke, R., Baehr, M., Naber, D., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.92 · Cited by 400 · see citing works
Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms
Heilig, M. A., & Egli, M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.001 · Cited by 378 · see citing works
Trial of prazosin for post-traumatic stress disorder in military veterans
Raskind, M. A., Peskind, E. R., Chow, B., Harris, C., Davis-Karim, A., Holmes, H. A., Hart, K. L., McFall, M., Mellman, T. A., Reist, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1507598 · Cited by 342 · see citing works
Self-citationLingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332 · see citing works
Behavioral Neurobiology of Alcohol Addiction: Recent Advances and Challenges
Weiss, F., & Porrino, L. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03332.2002 · Cited by 327 · see citing works
Krystal, J. H., Petrakis, I. L., Mason, G. F., Trevisan, L. A., & D’Souza, D. C. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00054-8 · Cited by 313 · see citing works
Self-citationIdentifying the neural circuitry of alcohol craving and relapse vulnerability
Heinz, A., Beck, A., Grüsser, S. M., Grace, A. A., & Wrase, J. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00136.x · Cited by 313 · see citing works
Pharmacotherapy for Alcohol Use Disorder
McPheeters, M. L., O’Connor, E., Riley, S., Kennedy, S. M., Voisin, C. E., Kuznacic, K., Coffey, C. P., Edlund, M. J., Bobashev, G., & Jonas, D. E. (2023) · JAMA · doi:10.1001/jama.2023.19761 · Cited by 304 · see citing works
Rösner, S., Leucht, S., Lehert, P., & Soyka, M. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107078308 · Cited by 300 · see citing works
Garbutt, J. C., Kampov‐Polevoy, A. B., Gallop, R., Kalka-Juhl, L. S., & Flannery, B. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01273.x · Cited by 290 · see citing works
Gambling Disorder and Other Behavioral Addictions: Recognition and Treatment
Yau, Y. H. C., & Potenza, M. N. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000051 · Cited by 267 · see citing works
Opioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867.pub2 · Cited by 266 · see citing works
Ray, L. A., & Hutchison, K. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1069 · Cited by 258 · see citing works
Myrick, H., Anton, R. F., Li, X., Henderson, S., Randall, P. K., & Voronin, K. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.466 · Cited by 258 · see citing works
Continuing care research: What we have learned and where we are going
McKay, J. R. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2008.10.004 · Cited by 249 · see citing works
Opioid antagonists for alcohol dependence
Rösner, S., Hackl-Herrwerth, A., Leucht, S., Vecchi, S., Srisurapanont, M., & Soyka, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867.pub3 · Cited by 246 · see citing works
Heinz, A., Reimold, M., Wrase, J., Hermann, D., Croissant, B., Mundle, G., Dohmen, B. M., Braus, D. H., Schumann, G., Machulla, H., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.1.57 · Cited by 241 · see citing works
The endogenous opioid system: A common substrate in drug addiction
Trigo, J. M., Martín‐García, E., Berrendero, F., Robledo, P., & Maldonado, R. J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.011 · Cited by 240 · see citing works
Oswald, L. M., & Wand, G. S. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.02.008 · Cited by 233 · see citing works
NORDBACK, I. H., Pelli, H., Lappalainen–Lehto, R., Järvinen, S., Räty, S., & Sand, J. A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.11.044 · Cited by 225 · see citing works
Krystal, J. H., Rosenheck, R. A., Cramer, J. A., Vessicchio, J. C., Jones, K. M., Vertrees, J. E., Horney, R. A., Huang, G. D., Stock, C. J., & for the Veterans Affairs Cooperative Study No. 504 Group (2011) · JAMA · doi:10.1001/jama.2011.1080 · Cited by 220 · see citing works
Self-citationFernández, A. J. C., Marcos, M., Mirón‐Canelo, J., Pastor, I., González‐Sarmiento, R., & Laso, F. J. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00442.x · Cited by 219 · see citing works
Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials
Srisurapanont, M., & Jarusuraisin, N. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004997 · Cited by 215 · see citing works
Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes
Cramer, J., Rosenheck, R., Kirk, G., Krol, W., & Krystal, J. (2003) · Value in Health · doi:10.1046/j.1524-4733.2003.65269.x · Cited by 212 · see citing works
Self-citationIs there a case for extended interventions for alcohol and drug use disorders?
McKay, J. R. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01208.x · Cited by 211 · see citing works
A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal
Myrick, H., Malcolm, R., Randall, P. K., Boyle, E., Anton, R. F., Becker, H. C., & Randall, C. L. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.00986.x · Cited by 201 · see citing works
Gelernter, J. E., Gueorguieva, R. V., Kranzler, H. R., Zhang, H., Cramer, J. A., Rosenheck, R. A., Krystal, J. H., & the VA Cooperative Study #425 Study Group (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00339.x · Cited by 201 · see citing works
Self-citationPharmacotherapy of Alcohol Dependence
Mann, K. F. (2004) · CNS Drugs · doi:10.2165/00023210-200418080-00002 · Cited by 198 · see citing works
Glutamatergic targets for new alcohol medications
Holmes, A., Spanagel, R., & Krystal, J. H. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3226-2 · Cited by 197 · see citing works
Self-citationLong-acting injectable naltrexone for the treatment of alcohol dependence
Mannelli, P., Peindl, K., Masand, P. S., & Patkar, A. A. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.10.1265 · Cited by 183 · see citing works
Parks, C. L., Wallack, S. S., Lee, S., McCarty, D. W., & Swift, R. M. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00319-7 · Cited by 183 · see citing works
Naltrexone for the Management of Alcohol Dependence
Anton, R. F. (2008) · New England Journal of Medicine · doi:10.1056/nejmct0801733 · Cited by 180 · see citing works
Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders
Petrakis, I. L., Poling, J., Levinson, C., Nich, C., Carroll, K., & Rounsaville, B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.016 · Cited by 177 · see citing works
Predicting response to opiate antagonists and placebo in the treatment of pathological gambling
Grant, J. E., Kim, S. W., Hollander, E., & Potenza, M. N. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1235-3 · Cited by 177 · see citing works
Adoption and implementation of new technologies in substance abuse treatment
Roman, P. M., & Johnson, J. A. (2002) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00241-6 · Cited by 177 · see citing works
The COMBINE Study Research Group (2003) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2003.tb02873.x · Cited by 174 · see citing works
Balldin, J., Berglund, M., Borg, S., Månsson, M., Bendtsen, P., Franck, J., Gustafsson, L., Halldin, J., Nilsson, L. ‐. H., Stolt, G., et al. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000075548.83053.a9 · Cited by 173 · see citing works
The Status of Naltrexone in the Treatment of Alcohol Dependence
Pettinati, H. M., O’Brien, C. P., Rabinowitz, A. R., Wortman, S. P., Oslin, D. W., Kampman, K. M., & Dackis, C. A. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000245566.52401.20 · Cited by 170 · see citing works
Kranzler, H. R., Wesson, D. R., Billot, L., & DrugAbuse Sciences Naltrexone Depot Study Group (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000130804.08397.29 · Cited by 169 · see citing works
Lingford-Hughes, A. R., Welch, S., & Nutt, D. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800321 · Cited by 168 · see citing works
Conceptual framework for the etiology of alcoholism: a “kindling”/stress hypothesis
Breese, G. R., Overstreet, D. H., & Knapp, D. J. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2016-2 · Cited by 167 · see citing works
Morley, K. C., Teesson, M., Reid, S., Sannibale, C., Thomson, C., Phung, N., Weltman, M., Bell, J. R., Richardson, K., & Haber, P. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01555.x · Cited by 165 · see citing works
Schroeder, J. P., Overstreet, D. H., & Hodge, C. W. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2175-9 · Cited by 161 · see citing works
How Can We Use Our Knowledge of Alcohol-Tobacco Interactions to Reduce Alcohol Use?
McKee, S. A., & Weinberger, A. H. (2012) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185549 · Cited by 160 · see citing works
Alcohol use disorders and current pharmacological therapies: the role of GABAA receptors
Liang, J., & Olsen, R. W. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.50 · Cited by 155 · see citing works
Johnson, J. A., Lee, A., Vinson, D. C., & Seale, J. P. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01898.x · Cited by 153 · see citing works
Baclofen for Alcohol Dependence: A Preliminary Open‐Label Study
Flannery, B., Garbutt, J. C., Cody, M. W., Renn, W., Grace, K., Osborne, M., Crosby, K., Morreale, M. K., & Trivette, A. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000141640.48924.14 · Cited by 152 · see citing works
Treatment of Alcohol Abuse: An Evidence‐Based Review
Berglund, M., Thelander, S., Salaspuro, M. P., Franck, J., Andréasson, S., & Öjehagen, A. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000090144.99832.19 · Cited by 151 · see citing works
O’Malley, S. S., Rounsaville, B. J., Farren, C. K., Namkoong, K., Wu, R., Robinson, J., & O’Connor, P. G. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.14.1695 · Cited by 141 · see citing works
Drobes, D. J., Anton, R. F., Thomas, S. E., & Voronin, K. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000139704.88862.01 · Cited by 140 · see citing works
State-of-the-art behavioral and pharmacological treatments for alcohol use disorder
Ray, L. A., Bujarski, S., Grodin, E. N., Hartwell, E. E., Green, R., Venegas, A., Lim, A. C., Gillis, A. J., & Miotto, K. A. (2018) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2018.1528265 · Cited by 136 · see citing works
Anton, R. F., Drobes, D. J., Voronin, K., Durazo-Avizu, R., & Moak, D. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1720-7 · Cited by 135 · see citing works
Tidey, J. W., Monti, P. M., Rohsenow, D. J., Gwaltney, C. J., Miranda, R., McGeary, J. E., MacKillop, J. M., Swift, R. M., Abrams, D. B., Shiffman, S. M., et al. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00545.x · Cited by 135 · see citing works
Guardia, J., Caso, C., Árias, F., Gual, A., Sanahuja, J., Ramírez, M., Mengual, I., Gonzalvo, B., Segura, L., Trujols, J., et al. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02682.x · Cited by 135 · see citing works
How Many Cravings? Pharmacological Aspects of Craving Treatment in Alcohol Addiction: A Review
Addolorato, G., Abenavoli, L., Leggio, L., & Gasbarrini, A. (2005) · Neuropsychobiology · doi:10.1159/000084161 · Cited by 133 · see citing works
Mr. ATOD’s Wild Ride: What Do Alcohol, Tobacco, and Other Drugs Have in Common?
Courtwright, D. T. (2005) · The Social History of Alcohol and Drugs · doi:10.1086/shad20010105 · Cited by 131 · see citing works
Pharmacotherapy of Alcohol Use Disorders: Seventy-Five Years of Progress
Zindel, L. R., & Kranzler, H. R. (2014) · Journal of Studies on Alcohol and Drugs Supplement · doi:10.15288/jsads.2014.s17.79 · Cited by 127 · see citing works
Parks, M. H., Dawant, B. M., Riddle, W. R., Hartmann, S. L., Dietrich, M. S., Nickel, M. K., Price, R. R., & Martin, P. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02681.x · Cited by 127 · see citing works
Comorbidity of Alcoholism and Psychiatric Disorders: An Overview
Petrakis, I. L., Gonzalez, G. M., Rosenheck, R. A., & Krystal, J. H. (2002) · Europe PMC (PubMed Central) · Cited by 127 · see citing works
Self-citationKarhuvaara, S., Simojoki, K., Virta, A., Rosberg, M., Löyttyniemi, E., Nurminen, T., Kallio, A., & Mäkelä, R. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00401.x · Cited by 126 · see citing works
Prevention of sudden unexpected death in epilepsy: A realistic goal?
Ryvlin, P., Nashef, L. A. M., & Tomson, T. (2013) · Epilepsia · doi:10.1111/epi.12180 · Cited by 124 · see citing works
Petrakis, I. L., Ralevski, E., Desai, N., Trevisan, L. A., Gueorguieva, R. V., Rounsaville, B. J., & Krystal, J. H. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.283 · Cited by 122 · see citing works
Self-citationAnton, R. F., Moak, D. H., Latham, P., Waid, L. R., Myrick, H., Voronin, K., Thevos, A., Wang, W., & Woolson, R. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000172071.81258.04 · Cited by 121 · see citing works
Understanding US addiction physicians' low rate of naltrexone prescription
Mark, T. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00134-0 · Cited by 120 · see citing works
Physicians’ opinions about medications to treat alcoholism
Mark, T. L., Kranzler, H. R., Song, X., Bransberger, P., Poole, V. H., & Crosse, S. B. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00377.x · Cited by 119 · see citing works
Genetics of alcohol dependence
Gelernter, J. E., & Kranzler, H. R. (2009) · Human Genetics · doi:10.1007/s00439-009-0701-2 · Cited by 118 · see citing works
Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia
Petrakis, I. L., O’Malley, S. S., Rounsaville, B. J., Poling, J. C., McHugh-Strong, C., & Krystal, J. H. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1658-9 · Cited by 118 · see citing works
Self-citationDonoghue, K., Zerbi, C. E., Saunders, R., Whittington, C. J., Pilling, S., & Drummond, C. (2015) · Addiction · doi:10.1111/add.12875 · Cited by 117 · see citing works
A Multi-site Dose Ranging Study of Nalmefene in the Treatment of Alcohol Dependence
Anton, R. F., Pettinati, H. M., Zweben, A., Kranzler, H. R., Johnson, B. A., Bohn, M. J., McCaul, M. E., Anthenelli, R. M., Salloum, I. M., Galloway, G. P., et al. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000130555.63254.73 · Cited by 117 · see citing works
β-Endorphin and drug-induced reward and reinforcement
Roth‐Deri, I., Green-Sadan, T., & Yadid, G. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.06.003 · Cited by 117 · see citing works
Mann, K. F., Leménager, T., Hoffmann, S., Reinhard, I., Hermann, D., Batra, A., Berner, M. M., Wodarz, N., Heinz, A., Smolka, M. N., et al. (2012) · Addiction Biology · doi:10.1111/adb.12012 · Cited by 116 · see citing works
Bergasa, N. V. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.004 · Cited by 112 · see citing works
From neurobiology to treatment: progress against addiction
Nestler, E. J. (2002) · Nature Neuroscience · doi:10.1038/nn945 · Cited by 111 · see citing works
Management of Alcohol Dependence in Patients with Liver Disease
Addolorato, G., Mirijello, A., Leggio, L., Ferrulli, A., & Landolfi, R. (2013) · CNS Drugs · doi:10.1007/s40263-013-0043-4 · Cited by 110 · see citing works
Harris, A. H. S., Oliva, E. M., Bowe, T. R., Humphreys, K. N., Kivlahan, D. R., & Trafton, J. A. (2012) · Psychiatric Services · doi:10.1176/appi.ps.201000553 · Cited by 110 · see citing works
Medications for treating alcohol dependence.
Williams, S. H. (2005) · PubMed · Cited by 110 · see citing works
A Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Acamprosate and Naltrexone
Mason, B. J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00368-8 · Cited by 110 · see citing works
Medical Treatment of Alcohol Dependence: A Systematic Review
Miller, P. M., Book, S. W., & Stewart, S. (2011) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.42.3.b · Cited by 109 · see citing works
A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence
DE SOUSA, A., & DE SOUSA, A. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh104 · Cited by 108 · see citing works
Pharmacotherapy for alcohol dependence: status of current treatments
Franck, J., & Jayaram-Lindström, N. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.05.005 · Cited by 107 · see citing works
Schacht, J. P., Randall, P. K., Latham, P. K., Voronin, K. E., Book, S. W., Myrick, H., & Anton, R. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.74 · Cited by 107 · see citing works
Pharmacotherapy of Alcohol Use Disorders in the Veterans Health Administration
Harris, A. H. S., Kivlahan, D. R., Bowe, T. R., & Humphreys, K. N. (2010) · Psychiatric Services · doi:10.1176/ps.2010.61.4.392 · Cited by 107 · see citing works
Pharmacological Relapse Prevention of Alcoholism: Clinical Predictors of Outcome
Kiefer, F., Helwig, H., Tarnaske, T., Otte, C., Jahn, H., & Wiedemann, K. (2005) · European Addiction Research · doi:10.1159/000083037 · Cited by 106 · see citing works
Barr, C. S., Schwandt, M., Lindell, S. G., Chen, S. A., Goldman, D., Suomi, S. J., Higley, J. D., & Heilig, M. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.369 · Cited by 105 · see citing works
Martinotti, G., Nicola, M. D., Giannantonio, M. D., & Janiri, L. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089596 · Cited by 102 · see citing works
- Authors
- Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A.
- Affiliations
- Yale University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-12-13
- Volume
- 345
- Issue
- 24
- Pages
- 1734-1739
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2108258874
- Cited by
- 618
- References
- 32
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 10 · 2023: 6 · 2022: 7 · 2021: 8 · 2020: 71 · 2019: 9 · 2018: 18 · 2017: 17 · 2016: 19 · 2015: 21 · 2014: 23 · 2013: 23 · 2012: 25
- FWCI
- 29.39
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- naltrexone, alcoholism, opioid antagonists, relapse prevention, veterans, adjunct pharmacotherapy, psychosocial interventions, Alcoholics Anonymous
- MeSH terms
- Alcoholics Anonymous, Alcoholism, Combined Modality Therapy, Counseling, Double-Blind Method, Female, Humans, Male, Middle Aged, Naltrexone, Narcotic Antagonists, Patient Compliance, Recurrence, Multivariate Analysis, Treatment Failure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
